Skip to main content
. 2020 Dec 9;9(2):693–701. doi: 10.1016/j.jaip.2020.11.054

Figure 2.

Figure 2

World map of asthma comorbidity rates in patients with COVID-19. The difference in asthma comorbidity rate is visualized as a colored world map, in which a darkening color represents higher prevalence. The asthma comorbidity rate was calculated as follows: for countries with 2 or more studies reporting the prevalence of asthma in patients with COVID-19, a meta-analysis was performed to estimate the pooled prevalence; for countries with only 1 study on asthma prevalence in patients with COVID-19, asthma prevalence was calculated as (total patients with COVID-19 with asthma)/(total patients with COVID-19).